Dionysus Digital Health: Unlocking Your Hidden Potential
Dionysus Digital Health is revolutionizing mental health care by combining cutting-edge epigenetics with advanced AI. By understanding your unique biological predispositions, Dionysus empowers you to proactively improve your mental well-being and build a more resilient future. With a recent new $10M injection of additional non-dilutive grant capital, Dionysus is now well positioned realize its vision to disrupt existing care models for female mental health by bringing to market the first simple, home based, blood and saliva tests capable of predicting the risk of postpartum depression and related mood disorders.
A core technological innovation is the development of a set of proprietary algorithms and custom epigenetic chip which can provide precision medical insights into modifiable, and environmental factors influencing predicted time to menopause, and hormonal health.
Dionysus CEO Dr. Andrea Cubitt started her professional career at the Howard Hughes Medical Institute at the University of California, San Diego where her work formed part of the research recognized by Nobel Prize for Chemistry awarded to Roger Tsien in 2008. Over the following years she has established a successful track record of bringing innovative technologies to the market, with three highly successful exits.
She co-founded Dionysus in 2020 with tech entrepreneur and AI expert Dr Vivienne Ming to help change the discussion on gender, and its interaction with stress, depression and mental illness. Building upon their personal experiences with estrogen, and through Dionysus they are bringing to the market the first AI based digital approaches for tracking depression which are seamless coupled to companion blood and saliva test for confirming hormonal sensitivity and identifying the most effective precision therapeutic strategies to address it. Their first product for predicting postpartum depression. The Enlighten Test™ is planned to be launched this year and will be closely followed by their second product for predicting perimenopausal depression.
In addition to receiving over $10M of research funding for their groundbreaking work, Dionysus has received numerous awards including winning the Ignite Golden Ticket entrance into Ignite’s women’s health accelerator program in Texas, and being accepted into the OneMind.org mental health accelerator in Palo Alto. Dionysus was also one of three finalists selected by the Association of Diagnostic and Laboratory Medicine’s 2024 Disruptive Technology award.
Co-Founders
Beyond Traditional Approaches: Personalized Insights and Actionable Guidance
Leveraging a decade of preliminary data demonstrating epigenetic connections to mental health vulnerability in women to identify biomarkers of hormonal sensitivity that underlie this vulnerability, Dionysus’s proposed solution is to commercialize a home-based and cost-effective system for precision psychiatry. Their system can accurately predict the risk of the development of postpartum depression and other related mood disorders and determine the best approaches to maximize treatment responses.
The Enlighten Test™ available this year
Improving Women’s Mental Health Through Integrated Home-Based Diagnostics and Precision Treatment
Mental illness disproportionately affects women, yet traditional diagnostic and treatment approaches often fall short. Dionysus is developing a transformative, cost-effective, and scalable platform to revolutionize women's mental health care.
Building on over a decade of research demonstrating the link between epigenetic markers and mental health vulnerability, they are creating an integrated home-based system that combines cutting-edge digital and biological analysis. This system can:
Empower women: Provide convenient, confidential, and accessible diagnostics via a home-based collection kit and secure data trust.
Enhance accuracy: Utilize a novel epigenetic chip and a sophisticated smartphone app to capture both biological and behavioral indicators, enabling precise diagnosis.
Personalize treatment: Leverage AI-driven algorithms to analyze integrated data and deliver precision mental health solutions.
Improve outcomes: Facilitate seamless integration with electronic health records and telehealth platforms for continuous monitoring and support.
By bridging the gap between cutting-edge research and real-world clinical practice, Dionysus aims to significantly improve the quality of life for millions of women.
Discover the power of personalized mental health care and Dionysus Digital Health’s innovative approach, and learn more about how you can support Dionysus by booking a call with us today.
